DISCOVER MORE
Our Corporate Access Portal serves as a tool to inform and engage investors by providing in-depth investor profiles for selected public companies and aims to facilitate meaningful one-on-one meetings between investors and company executives.
Investors can unlock captivating fireside chats and company webcasts; discover insightful KOL panels with public company executives and industry experts; and stay informed with real-time stock data, SEC filings, press releases and more.
Explore our Featured Companies and schedule your one-on-one meetings today!
From funding tailwinds to accelerating technology adoption, the Healthcare IT sector is entering a pivotal phase. In this video, Allen Klee of Maxim Group examines where the industry stands in the cycle, how federal initiatives and emerging technologies like AI are shaping adoption, and where investors may find compelling opportunities across the healthcare IT landscape.
RECENT NEWS
Smart Sand, Inc. Announces Fourth Quarter 2025 and Full Year 2025 Results
4Q 2025 and full year 2025 revenue of $86.0 million and $330.2 million, respectively.4Q 2025 and full year 2025 total tons sold of...
U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma’s Patent 11,697,028 To Be Unpatentable
WOBURN, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the...
PolyPid Announces Participation in Upcoming Investor Conferences
PETACH TIKVA, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), an innovative...
RECENT EVENTS
Aytu BioPharma (AYTU) Fireside Chat
Aytu BioPharma (Nasdaq: AYTU) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system...
Cadrenal Therapeutics (CVKD) Fireside Chat
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) is developing differentiated products designed to bridge critical gaps in current acute and chronic...
Alpha Tau (DRTS) Fireside Chat
Alpha Tau Medical (Nasdaq: DRTS) is the first company to develop a cancer therapy that releases an alpha radiating material for diffusion into...
